BRM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Bristol-Myers Squibb Co

Watchlist Manager

Watchlist

Price: 54.96 EUR 0.37% Market Closed

Market Cap: €111.4B

B	Bristol-Myers Squibb Co XETRA:BRM	US
C	Celldex Therapeutics Inc SWB:TCE2	US
	Danone SA OTC:DANOY	FR
	Knot Offshore Partners LP NYSE:KNOP	UK
	AltaGas Ltd TSX:ALA	CA
P	Pirelli and C. S.p.a SWB:2PI	IT
	Global Water Resources Inc NASDAQ:GWRS	US
	Meta Platforms Inc BMV:META	US
	SRT Marine Systems PLC OTC:SRTMF	UK
V	Vertex Pharmaceuticals Inc XETRA:VX1	US
T	Telefonica SA MIL:1TEF	ES
	Secom Co Ltd F:XSC0	JP
N	Nomura Holdings Inc DUS:NSE	JP
	Magis SpA F:ZF6	IT
D	Dai Nippon Printing Co Ltd OTC:DNPCF	JP

Profitability Summary

Bristol-Myers Squibb Co's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

72%

Strong 3Y Average Gross Margin

75%

Declining Gross Margin

77% > 72%

Exceptional Operating Margin

35%

Sustainable 3Y Average Operating Margin

29%

Operating Margin is Increasing

24% > 35%

Healthy Net Margin

19%

Low 3Y Average Net Margin

Net Margin is Increasing

18% > 19%

Exceptional Free Cash Flow Margin

34%

Strong 3Y Average Free Cash Flow Margin

30%

Free Cash Flow Margin is Increasing

24% > 34%

Exceptional ROE

82%

Positive 3Y Average ROE

Positive 3Y Average ROIC

18%

ROIC is Increasing

12% > 49%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.